C9093 Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
Short descriptor: Inj., susvimo, 0.1 mg
Look up C9093 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
C9093 is the HCPCS Level II code for Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.
Classification & CMS Attributes
- Section
- C: Outpatient PPS (Hospital)
- Medicare Coverage
- Special coverage instructions apply (code D)
- Part B Pricing
- Statute (indicator 53)
- Type of Service
- Other medical items or services
- Effective Date
- 2022-07-01
- Termination Date
- 2022-06-30
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference C9093 with the canonical source and edition:
C9093 — Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9093
Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9093